Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Editorial overview: New technologies: drug delivery and medical devices combinations, more than the sum of the parts.

Brayden DJ, Hirst BH.

Curr Opin Pharmacol. 2017 Oct;36:iv-vii. doi: 10.1016/j.coph.2017.11.007. No abstract available.

PMID:
29246370
2.

Streptococcus pyogenes infection of tonsil explants is associated with a human β-defensin 1 response from control but not recurrent acute tonsillitis patients.

Bell S, Howard A, Wilson JA, Abbot EL, Smith WD, Townes CL, Hirst BH, Hall J.

Mol Oral Microbiol. 2012 Jun;27(3):160-71. doi: 10.1111/j.2041-1014.2012.640.x. Epub 2012 Feb 13.

PMID:
22520386
3.

The glycine transporter GLYT1 in human intestine: expression and function.

Howard A, Hirst BH.

Biol Pharm Bull. 2011;34(6):784-8. Review.

4.

Roles of minor pilin subunits Spy0125 and Spy0130 in the serotype M1 Streptococcus pyogenes strain SF370.

Smith WD, Pointon JA, Abbot E, Kang HJ, Baker EN, Hirst BH, Wilson JA, Banfield MJ, Kehoe MA.

J Bacteriol. 2010 Sep;192(18):4651-9. doi: 10.1128/JB.00071-10. Epub 2010 Jul 16.

5.

Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage.

Howard A, Tahir I, Javed S, Waring SM, Ford D, Hirst BH.

J Physiol. 2010 Mar 15;588(Pt 6):995-1009. doi: 10.1113/jphysiol.2009.186262. Epub 2010 Feb 1.

6.

Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin.

Abbot EL, Smith WD, Siou GP, Chiriboga C, Smith RJ, Wilson JA, Hirst BH, Kehoe MA.

Cell Microbiol. 2007 Jul;9(7):1822-33. Epub 2007 Mar 13.

PMID:
17359232
7.

Expression and immunolocalisation of antimicrobial peptides within human palatine tonsils.

Ball SL, Siou GP, Wilson JA, Howard A, Hirst BH, Hall J.

J Laryngol Otol. 2007 Oct;121(10):973-8. Epub 2007 Feb 26.

PMID:
17319996
8.

Predicting oral drug absorption and hepatobiliary clearance: Human intestinal and hepatic in vitro cell models.

Fearn RA, Hirst BH.

Environ Toxicol Pharmacol. 2006 Feb;21(2):168-78. doi: 10.1016/j.etap.2005.06.002. Epub 2005 Aug 2.

PMID:
21783654
9.

The novel avian protein, AWAK, contains multiple domains with homology to protease inhibitory modules.

Nile CJ, Townes CL, Hirst BH, Hall J.

Mol Immunol. 2006 Feb;43(4):388-94. Epub 2005 Mar 31.

PMID:
16310052
10.

Antibiotic exposure does not influence MRP2 functional expression in Caco-2 cells.

Prime-Chapman H, Moore V, Hirst BH.

J Drug Target. 2005 Jan;13(1):1-6.

PMID:
15848949
11.

Who's talking to whom? Epithelial-bacterial pathogen interactions.

Aldridge PD, Gray MA, Hirst BH, Khan CM.

Mol Microbiol. 2005 Feb;55(3):655-63. Review.

12.

P-glycoprotein potentiates CYP3A4-mediated drug disappearance during Caco-2 intestinal secretory detoxification.

Chan LM, Cooper AE, Dudley AL, Ford D, Hirst BH.

J Drug Target. 2004;12(7):405-13.

PMID:
15621665
13.

Exploiting receptor biology for oral vaccination with biodegradable particulates.

Foster N, Hirst BH.

Adv Drug Deliv Rev. 2005 Jan 10;57(3):431-50. Review.

PMID:
15560950
14.

Identification of chicken lysozyme g2 and its expression in the intestine.

Nile CJ, Townes CL, Michailidis G, Hirst BH, Hall J.

Cell Mol Life Sci. 2004 Nov;61(21):2760-6.

PMID:
15549179
15.

Increased expression of specific intestinal amino acid and peptide transporter mRNA in rats fed by TPN is reversed by GLP-2.

Howard A, Goodlad RA, Walters JR, Ford D, Hirst BH.

J Nutr. 2004 Nov;134(11):2957-64.

PMID:
15514259
16.

Secretin and the exposition of hormonal control.

Hirst BH.

J Physiol. 2004 Oct 15;560(Pt 2):339. Epub 2004 Aug 12. No abstract available.

17.

Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.

Prime-Chapman HM, Fearn RA, Cooper AE, Moore V, Hirst BH.

J Pharmacol Exp Ther. 2004 Nov;311(2):476-84. Epub 2004 Jun 21.

PMID:
15210835
18.

M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.

Jepson MA, Clark MA, Hirst BH.

Adv Drug Deliv Rev. 2004 Mar 3;56(4):511-25. Review.

PMID:
14969756
19.

The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

Chan LM, Lowes S, Hirst BH.

Eur J Pharm Sci. 2004 Jan;21(1):25-51. Review.

PMID:
14706810
20.

Expression of the peptide transporter hPepT1 in human colon: a potential route for colonic protein nitrogen and drug absorption.

Ford D, Howard A, Hirst BH.

Histochem Cell Biol. 2003 Jan;119(1):37-43. Epub 2002 Dec 10.

PMID:
12548404
21.

Expression of junction-associated proteins differentiates mouse intestinal M cells from enterocytes.

Clark MA, Hirst BH.

Histochem Cell Biol. 2002 Aug;118(2):137-47. Epub 2002 Jun 28.

PMID:
12189517
22.

Water transport controversies--an overview.

Reuss L, Hirst BH.

J Physiol. 2002 Jul 1;542(Pt 1):1-2. No abstract available.

23.

K(+) recycling and gastric acid secretion.

Hirst BH.

J Physiol. 2002 Apr 1;540(Pt 1):1. Review. No abstract available.

24.

Targeting polymerised liposome vaccine carriers to intestinal M cells.

Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst BH.

Vaccine. 2001 Oct 12;20(1-2):208-17.

PMID:
11567766
25.

Exploiting M cells for drug and vaccine delivery.

Clark MA, Jepson MA, Hirst BH.

Adv Drug Deliv Rev. 2001 Aug 23;50(1-2):81-106. Review.

PMID:
11489335
26.

Glycine supply to human enterocytes mediated by high-affinity basolateral GLYT1.

Christie GR, Ford D, Howard A, Clark MA, Hirst BH.

Gastroenterology. 2001 Feb;120(2):439-48.

PMID:
11159884
27.

Differential cytokeratin and glycoconjugate expression by the surface and crypt epithelia of human palatine tonsils.

Clark MA, Wilson C, Sama A, Wilson JA, Hirst BH.

Histochem Cell Biol. 2000 Oct;114(4):311-21.

PMID:
11131096
28.

Lectin-mediated mucosal delivery of drugs and microparticles.

Clark MA, Hirst BH, Jepson MA.

Adv Drug Deliv Rev. 2000 Sep 30;43(2-3):207-23. Review.

PMID:
10967227
29.

Parietal cell membrane trafficking. Focus on "Expression of rab11a N124I in gastric parietal cells inhibits stimulatory recruitment of the H+-K+-ATPase".

Hirst BH.

Am J Physiol. 1999 Sep;277(3):C359-60. doi: 10.1152/ajpcell.1999.277.3.C359. Review. No abstract available.

PMID:
10484322
30.

Bacterial xylanase expression in mammalian cells and transgenic mice.

Fontes CM, Ali S, Gilbert HJ, Hazlewood GP, Hirst BH, Hall J.

J Biotechnol. 1999 Jun 11;72(1-2):95-101.

PMID:
10406100
31.
32.

Absorptive apical amiloride-sensitive Na+ conductance in human endometrial epithelium.

Matthews CJ, McEwan GT, Redfern CP, Thomas EJ, Hirst BH.

J Physiol. 1998 Dec 1;513 ( Pt 2):443-52.

33.
35.

Substrate upregulation of the human small intestinal peptide transporter, hPepT1.

Walker D, Thwaites DT, Simmons NL, Gilbert HJ, Hirst BH.

J Physiol. 1998 Mar 15;507 ( Pt 3):697-706.

36.
37.

Co-culture of two MDCK strains with distinct junctional protein expression: a model for intercellular junction rearrangement and cell sorting.

Collares-Buzato CB, Jepson MA, McEwan GT, Hirst BH, Simmons NL.

Cell Tissue Res. 1998 Feb;291(2):267-76.

PMID:
9426313
38.

Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo.

Foster N, Clark MA, Jepson MA, Hirst BH.

Vaccine. 1998 Mar;16(5):536-41.

PMID:
9491509
41.

Co-integration and expression of bacterial and genomic transgenes in the pancreatic and intestinal tissues of transgenic mice.

Ali S, Fontes CM, Hazlewood GP, Hirst BH, Clark AJ, Gilbert HJ, Hall J.

Gene. 1997 Nov 20;202(1-2):203-8.

PMID:
9427566
42.

Targeting to intestinal M cells.

Jepson MA, Clark MA, Foster N, Mason CM, Bennett MK, Simmons NL, Hirst BH.

J Anat. 1996 Dec;189 ( Pt 3):507-16.

43.

Promotion of Salmonella typhimurium adherence and membrane ruffling in MDCK epithelia by staurosporine.

Reed KA, Booth TA, Hirst BH, Jepson MA.

FEMS Microbiol Lett. 1996 Dec 1;145(2):233-8.

PMID:
8961561
44.

Invasion of murine intestinal M cells by Salmonella typhimurium inv mutants severely deficient for invasion of cultured cells.

Clark MA, Reed KA, Lodge J, Stephen J, Hirst BH, Jepson MA.

Infect Immun. 1996 Oct;64(10):4363-8.

45.

A protein targeting signal that functions in polarized epithelial cells in vivo.

Ali S, Hall J, Hazlewood GP, Hirst BH, Gilbert HJ.

Biochem J. 1996 May 1;315 ( Pt 3):857-62.

46.

Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo.

Clark MA, Jepson MA, Simmons NL, Hirst BH.

Cell Tissue Res. 1995 Dec;282(3):455-61.

PMID:
8581939
47.

Lectin binding defines and differentiates M-cells in mouse small intestine and caecum.

Clark MA, Jepson MA, Hirst BH.

Histochem Cell Biol. 1995 Aug;104(2):161-8.

PMID:
8536073
48.
49.

The resistance of cellulases and xylanases to proteolytic inactivation.

Fontes CM, Hall J, Hirst BH, Hazlewood GP, Gilbert HJ.

Appl Microbiol Biotechnol. 1995 Apr;43(1):52-7.

PMID:
7766136
50.

Evidence for a general role for non-catalytic thermostabilizing domains in xylanases from thermophilic bacteria.

Fontes CM, Hazlewood GP, Morag E, Hall J, Hirst BH, Gilbert HJ.

Biochem J. 1995 Apr 1;307 ( Pt 1):151-8.

Supplemental Content

Loading ...
Support Center